Comorbidity and ovarian cancer survival in Denmark, 1995-2005: A population-based cohort study

International Journal of Gynecological Cancer

Volumn 18, Issue 3, 2008, Pages 421-427

  Tetsche, M S ^a,b   Norgaard M ^a   Jacobsen, J ^a   Wogelius, P ^a   Sorensen H T ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Comorbidity; Epidemiology; Ovarian cancer; Prognosis

Indexed keywords

ADULT; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; COMORBIDITY; DENMARK; DISEASE SEVERITY; FEMALE; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SCORING SYSTEM;

ADULT; AGE DISTRIBUTION; AGED; CAUSE OF DEATH; COHORT STUDIES; COMORBIDITY; CONFIDENCE INTERVALS; DENMARK; FEMALE; HUMANS; INCIDENCE; KAPLAN-MEIERS ESTIMATE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROBABILITY; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 43449124090     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.01036.x     Document Type: Article

References (24)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005 55 : 74 108.
2. Sant M, Aareleid T, Berrino F et al. EUROCARE-3: survival of cancer patients diagnosed 1990-94 - results and commentary. Ann Oncol 2003 14 (Suppl. 5 v61 118.
3. Janssen-Heijnen ML, Houterman S, Lemmens VE, Louwman MW, Coebergh JW. Age and co-morbidity in cancer patients: a population-based approach. Cancer Treat Res 2005 124 : 89 107.
4. Sharma S, Driscoll D, Odunsi K, Venkatadri A, Lele S. Safety and efficacy of cytoreductive surgery for epithelial ovarian cancer in elderly and high-risk surgical patients. Am J Obstet Gynecol 2005 193 : 2077 82.
5. de Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity. A critical review of available methods. J Clin Epidemiol 2003 56 : 221 9.
6. Maas HA, Kruitwagen RF, Lemmens VE, Goey SH, Janssen-Heijnen ML. The influence of age and co-morbidity on treatment and prognosis of ovarian cancer: a population-based study. Gynecol Oncol 2005 97 : 104 9.
7. Janssen-Heijnen ML, Houterman S, Lemmens VE, Louwman MW, Maas HA, Coebergh JW. Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach. Crit Rev Oncol Hematol 2005 55 : 231 40.
8. O'Malley CD, Cress RD, Campleman SL, Leiserowitz GS. Survival of Californian women with epithelial ovarian cancer, 1994-1996: a population-based study. Gynecol Oncol 2003 91 : 608 15.
9. Du Bois A, Rochon J, Lamparter C, Pfisterer J. Pattern of care and impact of participation in clinical studies on the outcome in ovarian cancer. Int J Gynecol Cancer 2005 15 : 183 91.
10. Marx CI, Moller C, Bendixen A, Kehlet H, Ottesen BS. Ovarian cancer in Denmark. Status of the surgical intervention. Ugeskr Laeger 2006 168 : 1537 40.
11. Frank L. Epidemiology. When an entire country is a cohort. Science 2000 287 : 2398 9.
12. Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999 46 : 263 8.
13. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987 40 : 373 83.
14. Rothman KJ. Epidemiology: an introduction. Oxford : Oxford University Press, 2002.
15. Tetsche MS, Nørgaard M, Skriver MV, Andersen ES, Lash TL, Sørensen HT. Accuracy of ovarian cancer ICD-10 diagnosis in a Danish population-based hospital discharge registry. Eur J Gynaecol Oncol 2005 26 : 266 70.
16. Trimble CL, Trimble EL. Management of epithelial ovarian tumors of low malignant potential. Gynecol Oncol 1994 55 : S52 61.
17. Piccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel EL Jr. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 2004 291 : 2441 7.
18. Sørensen HT. Regional administrative health registries as a resource in clinical epidemiology. A study of options, strengths, limitations and data quality provided with example of use. Int J Risk Safety Med 1997 10 : 1 22.
19. Wilchesky M, Tamblyn RM, Huang A. Validation of diagnostic codes within medical services claims. J Clin Epidemiol 2004 57 : 131 41.
20. Tingulstad S, Skjeldestad FE, Halvorsen TB, Hagen B. Survival and prognostic factors in patients with ovarian cancer. Obstet Gynecol 2003 101 : 885 91.
21. DiSilvestro P, Peipert JF, Hogan JW, Granai CO. Prognostic value of clinical variables in ovarian cancer. J Clin Epidemiol 1997 50 : 501 5.
22. Read WL, Tierney RM, Page NC et al. Differential prognostic impact of comorbidity. J Clin Oncol 2004 22 : 3099 103.
23. Chan JK, Loizzi V, Lin YG, Osann K, Brewster WR, DiSaia PJ. Stages III and IV invasive epithelial ovarian carcinoma in younger versus older women: what prognostic factors are important? Obstet Gynecol 2003 102 : 156 61.
24. Brun JL, Feyler A, Chene G, Saurel J, Brun G, Hocke C. Long-term results and prognostic factors in patients with epithelial ovarian cancer. Gynecol Oncol 2000 78 : 21 7.